Share

October 16, 2012; 79 (16) Editorials

From Alois to Amyvid

Seeing Alzheimer disease

Ansgar J. Furst, Geoffrey A. Kerchner
First published July 11, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182662084
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
308

Share

Article Information

vol. 79 no. 16 1628-1629
DOI: 
https://doi.org/10.1212/WNL.0b013e3182662084
PubMed: 
22786589
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 11, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Ansgar J. Furst, PhD and
    2. Geoffrey A. Kerchner, MD, PhD
  1. Ansgar J. Furst, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, member of the editorial board, since 2012 Journal of Alzheimer’s Disease, associate editor, since 2012

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Geoffrey A. Kerchner, MD, PhD
    3. Scientific Advisory Boards:

    1. Serves on the clinical advisory board for Phloronol, Inc.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Serves as Associate Editor for Journal of Alzheimer’s Disease.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Receives royalties from publication of Current Medical Diagnosis and Treatment, McGraw Hill, 2011.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Received research funding from Johnson & Johnson.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Received research funding from the Alzheimer’s Association.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology and Neurological Sciences (A.J.F., G.A.K.) and Psychiatry and Behavioral Sciences (A.J.F.), Stanford University School of Medicine, Stanford, CA; and War Related Illness and Injury Study Center (WRIISC) (A.J.F.), VA Palo Alto Health Care System, Palo Alto, CA.
  1. Correspondence & reprint requests to Dr. Furst: ajfurst{at}stanford.edu
View Full Text

Article usage

Article usage: July 2012 to May 2023

AbstractFullPdfSource
Jul 201287031Highwire
Aug 201231027Highwire
Sep 201246018Highwire
Oct 201254495127Highwire
Nov 201201816Highwire
Dec 2012077Highwire
Jan 20130117Highwire
Feb 20130166Highwire
Mar 20130116Highwire
Apr 20130113Highwire
May 2013089Highwire
Jun 20132222Highwire
Jul 20132621Highwire
Aug 20132712Highwire
Sep 20132543Highwire
Oct 20132684Highwire
Nov 20132333Highwire
Dec 20131500Highwire
Jan 2014600Highwire
Feb 20141210Highwire
Mar 2014401Highwire
Apr 20141800Highwire
May 20141520Highwire
Jun 20142232Highwire
Jul 20141000Highwire
Aug 2014411Highwire
Sep 2014401Highwire
Oct 2014914Highwire
Nov 20141200Highwire
Dec 20141100Highwire
Jan 20151000Highwire
Feb 2015811Highwire
Mar 2015500Highwire
Apr 20151010Highwire
May 2015400Highwire
Jun 2015501Highwire
Jul 20153300Highwire
Aug 2015800Highwire
Sep 2015100Highwire
Oct 2015802Highwire
Nov 2015311Highwire
Dec 20151500Highwire
Jan 2016200Highwire
Feb 2016500Highwire
Mar 2016811Highwire
Apr 2016800Highwire
May 2016611Highwire
Jun 20161100Highwire
Jul 20161000Highwire
Aug 2016800Highwire
Sep 20161200Highwire
Oct 20161301Highwire
Nov 2016600Highwire
Dec 20161100Highwire
Jan 2017920Highwire
Feb 2017300Highwire
Mar 2017500Highwire
Apr 2017900Highwire
May 2017300Highwire
Jun 2017802Highwire
Jul 2017200Highwire
Aug 2017500Highwire
Sep 2017400Highwire
Oct 2017500Highwire
Nov 2017201Highwire
Dec 2017300Highwire
Jan 2018400Highwire
Feb 2018300Highwire
Mar 2018803Highwire
Apr 2018401Highwire
May 2018301Highwire
Jun 2018800Highwire
Jul 2018200Highwire
Aug 2018800Highwire
Sep 2018500Highwire
Oct 20181000Highwire
Nov 2018500Highwire
Dec 2018700Highwire
Jan 2019400Highwire
Feb 2019402Highwire
Mar 2019200Highwire
Apr 2019510Highwire
May 20193600Highwire
Jun 2019300Highwire
Jul 2019500Highwire
Aug 2019200Highwire
Oct 20191101Highwire
Nov 20191300Highwire
Dec 2019300Highwire
Jan 2020500Highwire
Feb 2020900Highwire
Mar 2020201Highwire
Apr 2020100Highwire
May 20201200Highwire
Jun 2020611Highwire
Jul 2020300Highwire
Aug 2020500Highwire
Sep 2020500Highwire
Oct 2020200Highwire
Nov 20201510Highwire
Dec 20201310Highwire
Jan 2021600Highwire
Feb 20211800Highwire
Mar 2021822Highwire
Apr 2021800Highwire
May 2021900Highwire
Jun 2021400Highwire
Jul 20211800Highwire
Aug 2021600Highwire
Sep 2021510Highwire
Oct 20211300Highwire
Nov 2021900Highwire
Dec 20211700Highwire
Feb 20221700Highwire
Mar 2022800Highwire
Apr 20221911Highwire
May 2022610Highwire
Jun 2022400Highwire
Jul 2022401Highwire
Aug 2022400Highwire
Sep 20221000Highwire
Oct 2022201Highwire
Nov 20221400Highwire
Dec 2022600Highwire
Jan 2023800Highwire
Feb 2023200Highwire
Mar 20231501Highwire
Apr 20231100Highwire
May 2023600Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles